29
JUL
2016

Cases Database- Unlocking the Value of Medical Case Reports

Somata Biotech, LLC has developed a novel platform for the treatment of Multiple Sclerosis (MS). Rather than ‘re-inventing the wheel’ through development of drugs, immunological factors (e.g. cytokines), or antibodies focused on symptomatic relief and functional improvement, Somata Bi
Continue Reading ?
29
JUL
2016

Research Subject Linda Friesen

Phase One trials are now complete and selective stem cell placement (SSCP) has been confirmed as a potential breakthrough therapy for the treatment of Multiple Sclerosis. SSCP is a delivery technology with a demonstrated scienti?c and clinical proof of concept. This is the first time
Continue Reading ?
05
JAN
2016

Fecal Microbiota Transplant

An example of alternative research we support are investigations into the efficacy of biomedical solutions for diseases such as C. Diff. and inflammatory bowel diseases. Fecal Microbiota Transplant (FMT) is a procedure in which fecal matter, or stool, is collected from a tested donor,
Continue Reading ?
05
JAN
2016

Importance of Basic Research

We support the work of Foundational Research. Here’s what our research associates say about our software. Somata Biotech LLC, is revolutionizing medicine by helping researchers follow their patients through our software. Only a narrow range of ‘evidence-based’ medicine is being
Continue Reading ?